Patent Number: 7,825,093

Title: Methods of using OSK1 peptide analogs

Abstract: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.

Inventors: Sullivan; John K. (Newbury Park, CA), McGivern; Joseph G. (Oak Park, CA), Miranda; Leslie P. (Thousand Oaks, CA)

Assignee: Amgen Inc.

International Classification: A61K 38/16 (20060101); C07K 14/00 (20060101); A61K 35/56 (20060101)

Expiration Date: 2019-11-02 0:00:00